AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
REGENXBIO to Participate in Investor Conferences in September 2025
ByAinvest
Thursday, Aug 28, 2025 7:08 am ET1min read
REGENXBIO will participate in several investor conferences, including the 2025 Wells Fargo Healthcare Conference, Morgan Stanley's 23rd Annual Global Healthcare Conference, Baird's 2025 Global Healthcare Conference, and H.C. Wainwright's 27th Annual Global Investment Conference. Live webcasts of select fireside chats can be accessed on REGENXBIO's website.
ReggenXBio Inc. (RGNX) has announced its participation in several significant investor conferences scheduled for 2025. The company will be presenting at the 2025 Wells Fargo Healthcare Conference, Morgan Stanley's 23rd Annual Global Healthcare Conference, Baird's 2025 Global Healthcare Conference, and H.C. Wainwright's 27th Annual Global Investment Conference. Live webcasts of select fireside chats will be available on the company's website, providing investors and financial professionals with an opportunity to engage with the company's leadership and learn more about its latest developments and strategies.These conferences are key events for the biotechnology sector, offering a platform for companies to update investors on their progress, discuss future prospects, and address any concerns or questions. By participating in these events, REGENXBIO aims to enhance its visibility, strengthen relationships with investors, and provide valuable insights into its growth plans and market opportunities.
The company's Chief Legal Officer, Patrick Christmas, will be leading the conference calls and presentations. The live webcasts will allow investors to follow along and participate in Q&A sessions, providing a direct line of communication between the company and its stakeholders.
REGENXBIO's participation in these conferences underscores its commitment to transparency and engagement with investors. The company's proactive approach to communication is a positive sign for investors looking to stay informed about the latest developments in the biotechnology sector.
References:
[1] https://finance.yahoo.com/quote/RGNX/earnings/RGNX-Q1-2025-earnings_call-337821.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments

No comments yet